200,000+ products from a single source!

sales@angenechem.com

Home > Nitro Compounds > 2942-40-7

2942-40-7

2942-40-7 | 1H-Indazole, 4-nitro-

CAS No: 2942-40-7 Catalog No: AG002YBO MDL No:MFCD00022784

Product Description

Catalog Number:
AG002YBO
Chemical Name:
1H-Indazole, 4-nitro-
CAS Number:
2942-40-7
Molecular Formula:
C7H5N3O2
Molecular Weight:
163.1335
MDL Number:
MFCD00022784
IUPAC Name:
4-nitro-1H-indazole
InChI:
InChI=1S/C7H5N3O2/c11-10(12)7-3-1-2-6-5(7)4-8-9-6/h1-4H,(H,8,9)
InChI Key:
WBTVZVUYPVQEIF-UHFFFAOYSA-N
SMILES:
[O-][N+](=O)c1cccc2c1cn[nH]2
NSC Number:
96892

Properties

Complexity:
192  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
163.038g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
163.136g/mol
Monoisotopic Mass:
163.038g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
74.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.4  

Literature

Title Journal
N-(7-Eth-oxy-1H-indazol-4-yl)-4-methyl-benzene-sulfonamide. Acta crystallographica. Section E, Structure reports online 20110601
Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation. Bioorganic & medicinal chemistry 20090901
4-substituted indazoles as new inhibitors of neuronal nitric oxide synthase. Bioorganic & medicinal chemistry letters 20070601
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Regioisomeric 4-nitroindazole N1- and N2-(beta-D-ribonucleosides). Acta crystallographica. Section C, Crystal structure communications 20040101
Regioselective synthesis of indazole N1- and N2-(beta-D-ribonucleosides). Nucleosides, nucleotides & nucleic acids 20040101

© 2019 Angene International Limited. All rights Reserved.